Health
J&J starts human study of COVID-19 vaccine after promising monkey data – Yahoo Finance
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published…
By Julie Steenhuysen
(Reuters) – Johnson & Johnson <JNJ.N> on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in na…
-
Noosa News13 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General14 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
General22 hours agoFormer Marine Paul Doyle pleads guilty to Liverpool FC parade car ramming charges
-
Noosa News14 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop